ADIM
G icon

Alpha DNA Investment Management’s Genpact G Stock Holding History

Alpha DNA Investment Management’s Portfolio G Stock Details G Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,756
Closed -$419K – 79
2024
Q4 		$419K Buy
+9,756
New +$412K 0.16% 163

Other funds holding G

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NIEF
Nalanda India Equity Fund Mauritius $510M AUM 23.61% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's G Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Genpact (G) in Q1 2025, closing a stake of 9,756 shares — an estimated $419K sold.

Alpha DNA Investment Management first reported a position in G in Q4 2024 and held it in 1 quarter. The position peaked at $419K in Q4 2024. 476 funds tracked by Wall St. Rank hold G as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Genpact position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 9,756 Genpact shares in Q1 2025, an estimated $419K.
  • Alpha DNA Investment Management first reported a position in Genpact in Q4 2024 and held it in 1 quarter.
  • Alpha DNA Investment Management's Genpact position peaked at $419K in Q4 2024.
  • 476 funds tracked by Wall St. Rank held Genpact as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.